查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1580033

連網型給藥市場：按產品、技術、治療領域、分銷管道和最終用戶 - 2025-2030 年全球預測

Connected Drug Delivery Devices Market by Product (Connected Injection Devices, Smart Inhalers, Smart Pills), Technology (Bluetooth, Near Field Communication, Wi-Fi), Therapy Area, Distribution Channel, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年連網型藥物輸送市場價值為8.5317億美元，預計到2024年將達到9.6622億美元，複合年成長率為14.45%，到2030年將達到21.9537億美元。

連網型藥物輸送是指先進的醫療設備，可實現藥物管理，同時實現患者用藥依從性和治療結果的即時監控和資料收集。由於對個人化醫療保健、以患者為中心的治療模式以及物聯網在醫療技術中的整合的需求不斷增加，這一範圍變得越來越重要。這些設備在慢性病管理領域有著重要的應用，包括使用連網型胰島素筆進行糖尿病管理、使用智慧吸入器進行氣喘治療以及使用穿戴式注射器進行腫瘤治療。主要最終用途包括醫院、家庭護理場所和門診病人設施，大大提高了患者的依從性並實現遠端監控。

主要市場統計
基準年[2023] 8.5317 億美元
預測年份 [2024] 96622萬美元
預測年份 [2030] 21.9537億美元
複合年成長率（%） 14.45%

市場正受到慢性病增加、數位健康技術進步以及人們日益關注降低醫療保健成本等因素的影響。最新的機會在於開發人工智慧主導的分析，以提高患者洞察力、增強設備互通性並擴展針對新出現的健康問題的應用。鼓勵公司投資與科技公司和醫療保健提供者的夥伴關係，以利用資料分析並提高設備的可訪問性。

然而，高開發成本、資料隱私問題和監管障礙等挑戰可能會阻礙成長。一些患者群體和醫療保健專業人員不願採用該技術，以及對設備可靠性和壽命的擔憂，也阻礙了市場滲透。創新應著重於提高這些設備的準確性和整合能力，開發自適應演算法以確保更準確的劑量和患者回饋循環。

此外，保護病患資料的網路安全措施也很重要。小型化和延長電池壽命方面的創新可以幫助其從競爭對手中脫穎而出。該市場的特點是技術發展速度快，需要相關人員不斷適應和適應。了解患者需求、監管環境和技術進步對於在這個充滿活力的市場中保持永續成長軌跡至關重要。

市場動態：揭示快速發展的連網型藥物輸送市場的關鍵市場洞察

供需的動態交互作用正在改變連網型的藥物輸送市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 世界各地慢性病和殘疾的增加
    • 連網型藥物傳輸的支持性監管核准
    • 政府支持政策，改善不同背景患者獲得醫療保健解決方案的機會
  • 市場限制因素
    • 連網型藥物傳遞的準確性和有效性的複雜性
  • 市場機會
    • 持續創新，提高連網型給藥的安全性和功能性
    • 採用連網型給藥進行個人化醫療的可能性
  • 市場挑戰
    • 與使用連網型藥物傳輸相關的隱私和資料安全問題

波特五力：駕馭連網型藥物傳輸市場的策略工具

波特的五力框架是了解連網型藥物輸送市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解連網型藥物輸送市場的外部影響

外部宏觀環境因素在塑造連網型藥物傳輸市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解連網型藥物輸送市場的競爭格局

對連網型藥物輸送市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣連網型藥物傳輸市場供應商的績效評估

FPNV 定位矩陣是評估連網型藥物傳輸市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了連網型藥物輸送市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，連網型藥物輸送市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性病和殘疾的發生率正在上升
      • 支持連網型藥物輸送的監管核准
      • 政府支持政策，改善不同背景病患獲得醫療保健解決方案的機會
    • 抑制因素
      • 連網型藥物傳遞準確性和有效性的複雜性
    • 機會
      • 持續創新，提高連網型給藥的安全性和功能性
      • 在個人化醫療中引入連網型藥物傳遞的可能性
    • 任務
      • 與使用連網型藥物傳輸相關的隱私問題和資料安全問題
  • 市場區隔分析
    • 產品：智慧吸入器的新進展與創新
    • 治療領域：需要連網型給藥以促進呼吸系統疾病的即時監測
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章連網型藥物傳輸市場：依產品

  • 連接注射裝置
  • 智慧吸入器
  • 智慧藥丸

第7章連網型藥物輸送市場：依技術分類

  • Bluetooth
  • 近距離場通訊
  • Wi-Fi

第8章依治療領域連網型藥物傳輸市場

  • 心血管疾病
  • 糖尿病
  • 神經病學
  • 呼吸系統疾病

第 9 章連網型藥物輸送市場：按分銷管道

  • 醫院及臨床藥房
  • 網路平台
  • 藥局

第 10 章連網型藥物輸送市場：依最終使用者分類

  • 家庭護理設置
  • 醫院/診所
  • 研發中心

第11章美洲連網型給藥市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太連網型藥物傳輸市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的連網型給藥市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Aptar Digital Health 與 SHL Medical 合作，透過自行注射給藥裝置改善患者體驗
    • Aherium 的智慧吸入器已被核准用於Astra Zeneca的設備，增強連網型藥物輸送
    • 新夥伴關係推出智慧型設備，用於氣喘和慢性阻塞性肺病的個人化護理
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Adherium Limited
  • AptarGroup, Inc.
  • Becton, Dickinson, and Company
  • Cognita Labs LLC
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Findair Sp. z oo
  • Gerresheimer AG
  • Medtronic PLC
  • Merck KGaA
  • Molex LLC
  • Novartis AG
  • Novo Nordisk A/S
  • OPKO Health, Inc.
  • Otsuka America, Inc.
  • Presspart Verwaltungs-GmbH
  • ResMed Inc.
  • SHL Medical AG
  • Sulzer Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-3C68ED2D0A4A

The Connected Drug Delivery Devices Market was valued at USD 853.17 million in 2023, expected to reach USD 966.22 million in 2024, and is projected to grow at a CAGR of 14.45%, to USD 2,195.37 million by 2030.

Connected Drug Delivery Devices refer to advanced medical devices that allow for the administration of medication while simultaneously enabling real-time monitoring and data collection concerning a patient's adherence and therapeutic outcomes. This scope is increasingly essential due to rising demands for personalized healthcare, patient-centric treatment models, and the integration of IoT in medical technologies. These devices find substantial application across chronic disease management, including diabetes management through connected insulin pens, asthma care via smart inhalers, and oncology treatments using wearable injectors. Hospitals, home care settings, and outpatient facilities constitute the primary end-use landscapes, significantly enhancing patient compliance and enabling remote monitoring.

KEY MARKET STATISTICS
Base Year [2023] USD 853.17 million
Estimated Year [2024] USD 966.22 million
Forecast Year [2030] USD 2,195.37 million
CAGR (%) 14.45%

The market is influenced by factors such as the increasing prevalence of chronic diseases, technological advancements in digital health, and a growing emphasis on reducing healthcare costs. Latest opportunities lie in developing AI-driven analytics for improved patient insights, enhancing device interoperability, and expanding applications across emerging health concerns. Companies are recommended to invest in partnerships with tech firms and healthcare providers to leverage data analytics and improve device accessibility.

However, challenges such as high development costs, data privacy issues, and regulatory hurdles may impede growth. Market penetration also suffers from resistance to technological adoption among some patient populations and healthcare professionals, alongside concerns about device reliability and lifetime. Innovation should focus on improving the accuracy and integration capabilities of these devices and developing adaptive algorithms that ensure more precise dosing and patient feedback loops.

Furthermore, emphasizing cybersecurity measures to safeguard patient data will be crucial. Innovations in miniaturization and battery life extension may drive competitive differentiation. The market is characterized by a fast-paced technological evolution, requiring continuous adaptation and resilience from stakeholders. Understanding patient needs, regulatory landscapes, and technological advancements are vital to maintaining a sustainable growth trajectory in this dynamic market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of chronic diseases and disorders across the world
    • Supportive regulatory approvals for connected drug delivery devices
    • Supportive government policies to improve access to healthcare solutions for patients from diverse backgrounds
  • Market Restraints
    • Complexities in the accuracy and efficacy of connected drug delivery devices
  • Market Opportunities
    • Ongoing innovations to improve the safety and functionality of connected drug delivery devices
    • Potential for the adoption of connected drug delivery devices for personalized medicine
  • Market Challenges
    • Privacy concerns and data security issues associated with the usage of connected drug delivery devices

Porter's Five Forces: A Strategic Tool for Navigating the Connected Drug Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Connected Drug Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Connected Drug Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Connected Drug Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Connected Drug Delivery Devices Market

A detailed market share analysis in the Connected Drug Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Connected Drug Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Connected Drug Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Connected Drug Delivery Devices Market

A strategic analysis of the Connected Drug Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Connected Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adherium Limited, AptarGroup, Inc., Becton, Dickinson, and Company, Cognita Labs LLC, Eli Lilly and Company, F. Hoffmann-La Roche AG, Findair Sp. z o. o., Gerresheimer AG, Medtronic PLC, Merck KGaA, Molex LLC, Novartis AG, Novo Nordisk A/S, OPKO Health, Inc., Otsuka America, Inc., Presspart Verwaltungs-GmbH, ResMed Inc., SHL Medical AG, Sulzer Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., West Pharmaceutical Services, Inc., Ypsomed Holding, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Connected Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Connected Injection Devices, Smart Inhalers, and Smart Pills.
  • Based on Technology, market is studied across Bluetooth, Near Field Communication, and Wi-Fi.
  • Based on Therapy Area, market is studied across Cardiovascular Diseases, Diabetes, Neurology, and Respiratory Diseases.
  • Based on Distribution Channel, market is studied across Hospitals & Clinical Pharmacies, Online Platforms, and Pharmacies.
  • Based on End User, market is studied across Homecare Settings, Hospitals & Clinics, and Research & Development Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of chronic diseases and disorders across the world
      • 5.1.1.2. Supportive regulatory approvals for connected drug delivery devices
      • 5.1.1.3. Supportive government policies to improve access to healthcare solutions for patients from diverse backgrounds
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities in the accuracy and efficacy of connected drug delivery devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations to improve the safety and functionality of connected drug delivery devices
      • 5.1.3.2. Potential for the adoption of connected drug delivery devices for personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Privacy concerns and data security issues associated with the usage of connected drug delivery devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging advancements and innovations in smart inhalers
    • 5.2.2. Therapy Area: Need for connected drug delivery devices to facilitate real-time monitoring of respiratory diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Connected Drug Delivery Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Connected Injection Devices
  • 6.3. Smart Inhalers
  • 6.4. Smart Pills

7. Connected Drug Delivery Devices Market, by Technology

  • 7.1. Introduction
  • 7.2. Bluetooth
  • 7.3. Near Field Communication
  • 7.4. Wi-Fi

8. Connected Drug Delivery Devices Market, by Therapy Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Diseases
  • 8.3. Diabetes
  • 8.4. Neurology
  • 8.5. Respiratory Diseases

9. Connected Drug Delivery Devices Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals & Clinical Pharmacies
  • 9.3. Online Platforms
  • 9.4. Pharmacies

10. Connected Drug Delivery Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Homecare Settings
  • 10.3. Hospitals & Clinics
  • 10.4. Research & Development Centers

11. Americas Connected Drug Delivery Devices Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Connected Drug Delivery Devices Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Connected Drug Delivery Devices Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Aptar Digital Health and SHL Medical Collaborate to Enhance Patient Experience with Self-Injectable Drug Delivery Devices
    • 14.3.2. Adherium's Smartinhaler Approved for Use with AstraZeneca Devices, Enhancing Connected Drug Delivery
    • 14.3.3. New Partnership Launches Smart Devices for Tailored Asthma and COPD Care
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Adherium Limited
  • 3. AptarGroup, Inc.
  • 4. Becton, Dickinson, and Company
  • 5. Cognita Labs LLC
  • 6. Eli Lilly and Company
  • 7. F. Hoffmann-La Roche AG
  • 8. Findair Sp. z o. o.
  • 9. Gerresheimer AG
  • 10. Medtronic PLC
  • 11. Merck KGaA
  • 12. Molex LLC
  • 13. Novartis AG
  • 14. Novo Nordisk A/S
  • 15. OPKO Health, Inc.
  • 16. Otsuka America, Inc.
  • 17. Presspart Verwaltungs-GmbH
  • 18. ResMed Inc.
  • 19. SHL Medical AG
  • 20. Sulzer Ltd.
  • 21. Teva Pharmaceutical Industries Ltd.
  • 22. Viatris Inc.
  • 23. West Pharmaceutical Services, Inc.
  • 24. Ypsomed Holding
  • 25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. CONNECTED DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONNECTED DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONNECTED DRUG DELIVERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CONNECTED INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMART INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMART PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEAR FIELD COMMUNICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY WI-FI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS & CLINICAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESEARCH & DEVELOPMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY THERAPY AREA, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023